Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease

Journal of Proteome Research

Volumn 8, Issue 11, 2009, Pages 5069-5079

  Gozal, Yair M ^a   Duong, Duc M ^a   Gearing, Marla ^a   Cheng, Dongmei ^a   Hanfelt, John J ^a   Funderburk, Christopher ^a   Peng, Junmin ^a   Lah, James J ^a   Levey, Allan I ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Detergent insoluble fractions; Proteomics

Indexed keywords

AMYLOID BETA PROTEIN; ANKYRIN; APOLIPOPROTEIN E; PROTEOME; SERINE PROTEINASE; STRATIFIN; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEOMICS; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ALZHEIMER DISEASE; CHROMATOGRAPHY, LIQUID; DETERGENTS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MOLECULAR SEQUENCE DATA; PROTEOME; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; TAU PROTEINS; UREA;

EID: 70449436388     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr900474t     Document Type: Article

References (71)

1. Blennow, K.; de Leon, M. J.; Zetterberg, H. Alzheimer's disease. Lancet 2006, 368 (9533), 387-403.
2. Bergamaschini, L.; Canziani, S.; Bottasso, B.; Cugno, M.; Braidotti, P.; Agostoni, A. Alzheimer's beta-amyloid peptides can activate the early components of complement classical pathway in a C1q-independent manner. Clin. Exp. Immunol. 1999, 115 (3), 526-533 (Pubitemid 29130371)
3. Goedert, M.; Spillantini, M. G. A century of Alzheimer's disease. Science 2006, 314 (5800), 777-781
4. Nunomura, A.; Perry, G.; Aliev, G.; Hirai, K.; Takeda, A.; Balraj, E. K.; Jones, P. K.; Ghanbari, H.; Wataya, T.; Shimohama, S.; Chiba, S.; Atwood, C. S.; Petersen, R. B.; Smith, M. A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60 (8), 759-767 (Pubitemid 32678256)
5. Tuppo, E. E.; Arias, H. R. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 2005, 37 (2), 289-305.
6. Ross, C. A.; Poirier, M. A. Protein aggregation and neurodegenerative disease. Nat. Med. 2004, (10 Suppl.), S10-7.
7. Glenner, G. G.; Wong, C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 1984, 120 (3), 885-890 (Pubitemid 14104991)
8. Lee, V. M.; Balin, B. J.; Otvos, L., Jr.; Trojanowski, J. Q. A68: a major subunit of paired helical filaments and derivatized forms of normal Tau. Science 1991, 251 (4994), 675-678
9. Masters, C. L.; Simms, G.; Weinman, N. A.; Multhaup, G.; Mc-Donald, B. L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U.S.A. 1985, 82 (12), 4245-4249
10. Atwood, C. S.; Martins, R. N.; Smith, M. A.; Perry, G. Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins. Peptides 2002, 23 (7), 1343-1350 (Pubitemid 34786713)
11. Butterfield, D. A.; Castegna, A. Proteomics for the identification of specifically oxidized proteins in brain: technology and application to the study of neurodegenerative disorders. Amino Acids 2003, 25 (3-4), 419-425 (Pubitemid 38041276)
12. Tsuji, T.; Shimohama, S. Analysis of the proteomic profiling of brain tissue in Alzheimer's disease. Dis. Markers 2001, 17 (4), 247-257 (Pubitemid 34014680)
13. Mattila, K. M.; Frey, H. Alzheimer brain proteins investigated by two-dimensional gel electrophoresis with immobilized pH gradients in the first dimension. Electrophoresis 1994, 15 (5), 721-725 (Pubitemid 24181998)
14. Tsuji, T.; Shimohama, S.; Kamiya, S.; Sazuka, T.; Ohara, O. Analysis of brain proteins in Alzheimer's disease using high-resolution two-dimensional gel electrophoresis. J. Neurol. Sci. 1999, 166 (2), 100-106 (Pubitemid 29339080)
15. Tsuji, T.; Shiozaki, A.; Kohno, R.; Yoshizato, K.; Shimohama, S. Proteomic profiling and neurodegeneration in Alzheimer's disease. Neurochem. Res. 2002, 27 (10), 1245-1253 (Pubitemid 35316120)
16. Cottrell, B. A.; Galvan, V.; Banwait, S.; Gorostiza, O.; Lombardo, C. R.; Williams, T.; Schilling, B.; Peel, A.; Gibson, B.; Koo, E. H.; Link, C. D.; Bredesen, D. E. A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease. Ann. Neurol. 2005, 58 (2), 277-289 (Pubitemid 41098885)
17. Palzkill, T. Proteomics; Kluwer Academic Publishers: Boston, MA, 2002; p 127.
18. Aebersold, R.; Mann, M. Mass spectrometry-based proteomics. Nature 2003, 422 (6928), 198-207.
19. McCormack, A. L.; Schieltz, D. M.; Goode, B.; Yang, S.; Barnes, G.; Drubin, D.; Yates, J. R., III. Direct analysis and identification of proteins in mixtures by LC/MS/MS and database searching at the low-femtomole level. Anal. Chem. 1997, 69 (4), 767-776 (Pubitemid 127491067)
20. Liao, L.; Cheng, D.; Wang, J.; Duong, D. M.; Losik, T. G.; Gearing, M.; Rees, H. D.; Lah, J. J.; Levey, A. I.; Peng, J. Proteomic characterization of postmortem amyloid plaques isolated by laser capture microdissection. J. Biol. Chem. 2004, 279 (35), 37061-37068 (Pubitemid 39129056)
21. Gozal, Y. M.; Cheng, D.; Duong, D. M.; Lah, J. J.; Levey, A. I.; Peng, J. Merger of laser capture microdissection and mass spectrometry: a window into the amyloid plaque proteome. Methods Enzymol. 2006, 412, 77-93. (Pubitemid 44548575)
22. Wang, Q.; Woltjer, R. L.; Cimino, P. J.; Pan, C.; Montine, K. S.; Zhang, J.; Montine, T. J. Proteomic analysis of neurofibrillary tangles in Alzheimer disease identifies GAPDH as a detergent-insoluble paired helical filament tau binding protein. FASEB J. 2005, 19 (7), 869-871
23. Woltjer, R. L.; Cimino, P. J.; Boutte, A. M.; Schantz, A. M.; Montine, K. S.; Larson, E. B.; Bird, T.; Quinn, J. F.; Zhang, J.; Montine, T. J. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. FASEB J. 2005, 19 (13), 1923-1925
24. Hynd, M. R.; Lewohl, J. M.; Scott, H. L.; Dodd, P. R. Biochemical and molecular studies using human autopsy brain tissue. J. Neurochem. 2003, 85 (3), 543-562
25. Fountoulakis, M.; Hardmeier, R.; Hoger, H.; Lubec, G. Postmortem changes in the level of brain proteins. Exp. Neurol. 2001, 167 (1), 86-94. (Pubitemid 32066411)
26. Kim, S. I.; Voshol, H.; van Oostrum, J.; Hastings, T. G.; Cascio, M.; Glucksman, M. J. Neuroproteomics: expression profiling of the brain's proteomes in health and disease. Neurochem. Res. 2004, 29 (6), 1317-1331
27. Leger, D. W.; Didrichsons, I. An assessment of data pooling and some alternatives. Anim. Behav. 1994, 48, 823-832. (Pubitemid 2143973)
28. Terry, R. D.; Katzman, R. Senile dementia of the Alzheimer type. Ann. Neurol. 1983, 14 (5), 497-506.
29. Mitsui, K.; Doi, H.; Nukina, N. Proteomics of polyglutamine aggregates. Methods Enzymol. 2006, 412, 63-76.
30. Neumann, M.; Sampathu, D. M.; Kwong, L. K.; Truax, A. C.; Micsenyi, M. C.; Chou, T. T.; Bruce, J.; Schuck, T.; Grossman, M.; Clark, C. M.; McCluskey, L. F.; Miller, B. L.; Masliah, E.; Mackenzie, I. R.; Feldman, H.; Feiden, W.; Kretzschmar, H. A.; Trojanowski, J. Q.; Lee, V. M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314 (5796), 130-133
31. Mirra, S. S.; Heyman, A.; McKeel, D.; Sumi, S. M.; Crain, B. J.; Brownlee, L. M.; Vogel, F. S.; Hughes, J. P.; van Belle, G.; Berg, L. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Neurology 1991, 41 (4), 479-486
32. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997, 18 (4 Suppl.), S1-2.
33. McKhann, G. M.; Albert, M. S.; Grossman, M.; Miller, B.; Dickson, D.; Trojanowski, J. Q. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Fronto-temporal Dementia and Pick's Disease. Arch. Neurol. 2001, 58 (11), 1803-1809
34. Trojanowski, J. Q.; Dickson, D. Update on the neuropathological diagnosis of frontotemporal dementias. J. Neuropathol. Exp. Neurol. 2001, 60 (12), 1123-1126 (Pubitemid 33117093)
35. Shevchenko, A.; Wilm, M.; Vorm, O.; Mann, M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 1996, 68 (5), 850-858 (Pubitemid 26101214)
36. Peng, J.; Gygi, S. P. Proteomics: the move to mixtures. J. Mass Spectrom. 2001, 36 (10), 1083-1091
37. Eng, J.; McCormack, A. L.; Yates, J. R., III. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994, 5, 976-989
38. Peng, J.; Elias, J. E.; Thoreen, C. C.; Licklider, L. J.; Gygi, S. P. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2003, 2 (1), 43-50.
39. Andersen, J. S.; Wilkinson, C. J.; Mayor, T.; Mortensen, P.; Nigg, E. A.; Mann, M. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 2003, 426 (6966), 570-574 (Pubitemid 37522644)
40. Bondarenko, P. V.; Chelius, D.; Shaler, T. A. Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry. Anal. Chem. 2002, 74 (18), 4741-4749
41. Wang, W.; Zhou, H.; Lin, H.; Roy, S.; Shaler, T. A.; Hill, L. R.; Norton, S.; Kumar, P.; Anderle, M.; Becker, C. H. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal. Chem. 2003, 75 (18), 4818-4826
42. Cheng, D.; Hoogenraad, C. C.; Rush, J.; Ramm, E.; Schlager, M. A.; Duong, D. M.; Xu, P.; Wijayawardana, S. R.; Hanfelt, J.; Nakagawa, T.; Sheng, M.; Peng, J. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol. Cell. Proteomics 2006, 5 (6), 1158-1170
43. Li, X. J.; Zhang, H.; Ranish, J. A.; Aebersold, R. Automated statistical analysis of protein abundance ratios from data generated by stable-isotope dilution and tandem mass spectrometry. Anal. Chem. 2003, 75 (23), 6648-6657 (Pubitemid 37493927)
44. Allison, D. B.; Cui, X.; Page, G. P.; Sabripour, M. Microarray data analysis: from disarray to consolidation and consensus. Nat. Rev. 2006, 7 (1), 55-65. (Pubitemid 41828948)
45. Kendziorski, C. M.; Zhang, Y.; Lan, H.; Attie, A. D. The efficiency of pooling mRNA in microarray experiments. Biostatistics 2003, 4 (3), 465-477
46. Roxas, B. A.; Li, Q. Significance analysis of microarray for relative quantitation of LC/MS data in proteomics. BMC Bioinf. 2008, 9, 187. (Pubitemid 351584197)
47. Xu, F.; Vitek, M. P.; Colton, C. A.; Previti, M. L.; Gharkholonarehe, N.; Davis, J.; Van Nostrand, W. E. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. J. Neurosci. 2008, 28 (20), 5312-5320
48. Fryer, J. D.; Simmons, K.; Parsadanian, M.; Bales, K. R.; Paul, S. M.; Sullivan, P. M.; Holtzman, D. M. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model. J. Neurosci. 2005, 25 (11), 2803-2810
49. Pallitto, M. M.; Murphy, R. M. A mathematical model of the kinetics of beta-amyloid fibril growth from the denatured state. Biophys. J. 2001, 81 (3), 1805-1822
50. Sahara, N.; Lewis, J.; DeTure, M.; McGowan, E.; Dickson, D. W.; Hutton, M.; Yen, S. H. Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility. J. Neurochem. 2002, 83 (6), 1498-1508
51. Morishima-Kawashima, M.; Ihara, Y. Alzheimer's disease: beta-Amyloid protein and tau. J. Neurosci. Res. 2002, 70 (3), 392-401. (Pubitemid 35222378)
52. Kuret, J.; Congdon, E. E.; Li, G.; Yin, H.; Yu, X.; Zhong, Q. Evaluating triggers and enhancers of tau fibrillization. Microsc. Res. Tech. 2005, 67 (3-4), 141-155 (Pubitemid 41243632)
53. Lansbury, P. T., Jr. Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl. Acad. Sci. U.S.A. 1999, 96 (7), 3342-3344
54. Kim, J. R.; Muresan, A.; Lee, K. Y.; Murphy, R. M. Urea modulation of beta-amyloid fibril growth: experimental studies and kinetic models. Protein Sci. 2004, 13 (11), 2888-2898
55. Weinkauf, M.; Hiddemann, W.; Dreyling, M. Sample pooling in 2-D gel electrophoresis: a new approach to reduce nonspecific expression background. Electrophoresis 2006, 27 (22), 4555-4558 (Pubitemid 44869610)
56. Strittmatter, W. J.; Roses, A. D. Apolipoprotein E and Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 1995, 92 (11), 4725-4727
57. Rostagno, A.; Lashley, T.; Ng, D.; Meyerson, J.; Braendgaard, H.; Plant, G.; Bojsen-Moller, M.; Holton, J.; Frangione, B.; Revesz, T.; Ghiso, J. Preferential association of serum amyloid P component with fibrillar deposits in familial British and Danish dementias: similarities with Alzheimer's disease. J. Neurol. Sci. 2007, 257 (1-2), 88-96.
58. Yasojima, K.; Schwab, C.; McGeer, E. G.; McGeer, P. L. Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 1999, 154 (3), 927-936 (Pubitemid 29122612)
59. Navarro, A.; Del Valle, E.; Astudillo, A.; Gonzalez del Rey, C.; Tolivia, J. Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits. Exp. Neurol. 2003, 184 (2), 697-704. (Pubitemid 38182798)
60. Wilhelmus, M. M.; Otte-Holler, I.; Wesseling, P.; de Waal, R. M.; Boelens, W. C.; Verbeek, M. M. Specific association of small heat shock proteins with the pathological hallmarks of Alzheimer's disease brains. Neuropathol. Appl. Neurobiol. 2006, 32 (2), 119-130
61. Nakamura, Y.; Takeda, M.; Suzuki, H.; Hattori, H.; Tada, K.; Hariguchi, S.; Hashimoto, S.; Nishimura, T. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease. Neurosci. Lett. 1991, 130 (2), 195-198
62. McMurray, C. T. Neurodegeneration: diseases of the cytoskeleton. Cell Death Differ. 2000, 7 (10), 861-865
63. Xia, Q.; Cheng, D.; Duong, D. M.; Gearing, M.; Lah, J. J.; Levey, A. I.; Peng, J. Phosphoproteomic analysis of human brain by calcium phosphate precipitation and mass spectrometry. J. Proteome Res. 2008, 7 (7), 2845-2851
64. Bennett, V.; Healy, J. Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol. Med. 2008, 14 (1), 28-36.
65. Bennett, V.; Lambert, S. Physiological roles of axonal ankyrins in survival of premyelinated axons and localization of voltage-gated sodium channels. J. Neurocytol. 1999, 28 (4-5), 303-318 (Pubitemid 30321012)
66. von Janowsky, B.; Knapp, K.; Major, T.; Krayl, M.; Guiard, B.; Voos, W. Structural properties of substrate proteins determine their proteolysis by the mitochondrial AAA+ protease Pim1. Biol. Chem. 2005, 386 (12), 1307-1317 (Pubitemid 41790814)
67. Bota, D. A.; Davies, K. J. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat. Cell Biol. 2002, 4 (9), 674-680
68. Atamna, H.; Frey, W. H., II. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer's disease. Mitochondrion 2007, 7 (5), 297-310. (Pubitemid 47300175)
69. Fukui, H.; Moraes, C. T. The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis. Trends Neurosci. 2008, 31 (5), 251-256
70. Zhang, Y.; Marcillat, O.; Giulivi, C.; Ernster, L.; Davies, K. J. The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 1990, 265 (27), 16330-16336 (Pubitemid 20324507)
71. Shin, S. J.; Lee, S. E.; Boo, J. H.; Kim, M.; Yoon, Y. D.; Kim, S. I.; Mook-Jung, I. Profiling proteins related to amyloid deposited brain of Tg2576 mice. Proteomics 2004, 4 (11), 3359-3368 (Pubitemid 39525284)